Vyriad Inc.
Rochester, MN
- UEI
- P4J2W42KVHQ7
- CAGE
- 70LF7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2900 37th St NW Bldg 110, Rochester, MN 55901, USA
- Website
- vyriad.com
- Founded
- 2015
- Employees
- 51-250
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors | National Cancer Institute (NIH) | $2,060,949 | |
| Intravesical oncolytic therapy for bladder cancer | National Cancer Institute (NIH) | $1,990,950 |
Quick answers
Is Vyriad Inc. registered in SAM.gov?
Yes. Vyriad Inc.'s SAM.gov registration is active through September 29, 2027.
What is Vyriad Inc.'s most recent federal award?
Vyriad Inc.'s most recent federal grant award is Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors (R44CA233024), from National Cancer Institute (NIH), on September 20, 2018.
On GovTribe
See Vyriad Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors